Insider Shareholders with Indirect Ownership of Dexcom Inc (DXCM)
This section provides a comprehensive overview of the insiders with indirect ownership of Dexcom Inc (DXCM). You can find the latest updates on their holdings.
DEXCOM INC Insider List
| Insider | Adquired | Disposed | # of Trades |
|---|---|---|---|
|
Andrew K Balo
EVP Regulatory Strategy Clinic |
21,272 | 13,719 | 6 |
|
Richard Doubleday
EVP Chief Commercial Officer |
13,313 | 6,659 | 7 |
|
Mark G Foletta
Director |
9,743 | 9,500 | 11 |
|
Richard Alexander Collins
Director |
8,551 | 1,500 | 5 |
|
Eric Topol
Director |
8,615 | 0 | 4 |
|
Nicholas Augustinos
Director |
7,937 | 9,918 | 8 |
|
Karen M Dahut
Director |
11,251 | 0 | 6 |
|
Steven R Altman
Director |
8,517 | 9,568 | 10 |
|
Barbara Kahn
Director |
8,608 | 4,666 | 5 |
|
Jay S Skyler
Director |
5,598 | 20,000 | 4 |